Robert Shenkar

Robert Shenkar

University of Chicago

H-index: 48

North America-United States

About Robert Shenkar

Robert Shenkar, With an exceptional h-index of 48 and a recent h-index of 31 (since 2020), a distinguished researcher at University of Chicago, specializes in the field of Cerebral Cavernous Malformations, Hemorrhagic Stroke, RhoA Pathway, Genomics, Magnetic Resonance Imaging.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling

Abstract TP12: Changes in Plasma Metabolites Reflect Lesional Iron Content and Permeability Imaging as Monitoring Biomarkers of Hemorrhage in Cavernous Angiomas

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

Trial readiness of cavernous malformations with symptomatic hemorrhage, part I: event rates and clinical outcome

mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice

Corrigendum to" Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu"[J. Autoimmun. 113 (2020) 102469]

Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation

Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease

Robert Shenkar Information

University

Position

Research Associate (Assistant Professor) Department of Surgery

Citations(all)

8239

Citations(since 2020)

2786

Cited By

6465

hIndex(all)

48

hIndex(since 2020)

31

i10Index(all)

85

i10Index(since 2020)

58

Email

University Profile Page

Google Scholar

Robert Shenkar Skills & Research Interests

Cerebral Cavernous Malformations

Hemorrhagic Stroke

RhoA Pathway

Genomics

Magnetic Resonance Imaging

Top articles of Robert Shenkar

Mild Hypoxia Accelerates Cerebral Cavernous Malformation Disease Through CX3CR1-CX3CL1 Signaling

Arteriosclerosis, Thrombosis, and Vascular Biology

2024/4/25

Abstract TP12: Changes in Plasma Metabolites Reflect Lesional Iron Content and Permeability Imaging as Monitoring Biomarkers of Hemorrhage in Cavernous Angiomas

Stroke

2024/2

Transcriptomic signatures of individual cell types in cerebral cavernous malformation

Cell Communication and Signaling

2024/1/9

Trial readiness of cavernous malformations with symptomatic hemorrhage, part I: event rates and clinical outcome

Stroke

2024/1

mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice

Stroke

2023/11

Corrigendum to" Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu"[J. Autoimmun. 113 (2020) 102469]

Journal of autoimmunity

2023/9/23

Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation

2023/9/17

Impact of socioeconomics and race on clinical follow-up and trial enrollment and adherence in cerebral cavernous malformation

Journal of Stroke and Cerebrovascular Diseases

2023/7/1

Brain tumor like vascular anomaly: Pragmatic management

Interdisciplinary Neurosurgery

2023/6/1

Robert Shenkar
Robert Shenkar

H-Index: 23

Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease)

2023/4

Robert Shenkar
Robert Shenkar

H-Index: 23

Abstract WP17: Plasma Proteins In Correlation With Lesional Iron Content And Permeability Imaging In Clinical Trial Of Cavernous Angioma With Symptomatic Hemorrhage

Stroke

2023/2

Abstract HUP14: Impact Of Socioeconomic Status And Race On The Access To Specialized Care And Enrollment/adherence In Clinical Trial In Cerebral Cavernous Malformations

Stroke

2023/2

Changes In Quantitative Susceptibility Mapping On Magnetic Resonance Imaging During Prospective Follow-Up Of Cavernous Angiomas With Symptomatic Hemorrhage In Trial Readiness …

Stroke

2023/2

Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling

medRxiv

2023

Credulity of exploratory trials for cerebral cavernous malformations

The Lancet Neurology

2023/1/1

Robert Shenkar
Robert Shenkar

H-Index: 23

β1 integrin monoclonal antibody treatment ameliorates cerebral cavernous malformations

FASEB journal: official publication of the Federation of American Societies for Experimental Biology

2022/12

Perfusion and permeability MRI predicts future cavernous angioma hemorrhage and growth

Journal of Magnetic Resonance Imaging

2022/5

See List of Professors in Robert Shenkar University(University of Chicago)